A Multicenter Phase II Trial of Post-operative Concurrent Chemoradiotherapy Using Weekly Cisplatin With Tislelizumab for Patients With High-risk Head and Neck Squamous Cell Carcinoma：The POTENTIAL Study

Clinical trial NCT04814069 · UNKNOWN

Trial details

NCT number: NCT04814069
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Radiation PD-1

Start date: 2021-04-01
Primary completion: 2023-04-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.